ArticleFrontiers in immunology2024

Case report: A golden tail of immunotherapy: significant tail effect in a chemotherapy-resistant advanced pulmonary sarcomatoid carcinoma patient treated by Sintilimab combined with Anlotinib.

Chenghao Fu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.